HORTOVÁ KOHOUTKOVÁ, Marcela, Federico TIDU, Marco DE ZUANI, Vladimír ŠRÁMEK, Martin HELÁN and Jan FRIC. PHAGOCYTOSIS-INFLAMMATION CROSSTALK IN SEPSIS: NEW AVENUES FOR THERAPEUTIC INTERVENTION. Shock. Philadelphia: Lippincott Williams & Wilkins, 2020, vol. 54, No 5, p. 606-614. ISSN 1073-2322. Available from: https://dx.doi.org/10.1097/SHK.0000000000001541.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name PHAGOCYTOSIS-INFLAMMATION CROSSTALK IN SEPSIS: NEW AVENUES FOR THERAPEUTIC INTERVENTION
Authors HORTOVÁ KOHOUTKOVÁ, Marcela (203 Czech Republic), Federico TIDU (380 Italy), Marco DE ZUANI, Vladimír ŠRÁMEK (203 Czech Republic, belonging to the institution), Martin HELÁN (203 Czech Republic, belonging to the institution) and Jan FRIC (203 Czech Republic).
Edition Shock, Philadelphia, Lippincott Williams & Wilkins, 2020, 1073-2322.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30212 Surgery
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.454
RIV identification code RIV/00216224:14110/20:00118327
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1097/SHK.0000000000001541
UT WoS 000619501000004
Keywords in English Monocyte; phagocytosis; sepsis; signaling
Tags 14110122, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 4/3/2021 07:49.
Abstract
Phagocytosis is a complex process by which cells within most organ systems remove pathogens and cell debris. Phagocytosis is usually followed by inflammatory pathway activation, which promotes pathogen elimination and inhibits pathogen growth. Delayed pathogen elimination is the first step in sepsis development and a key factor in sepsis resolution. Phagocytosis thus has an important role during sepsis and likely contributes to all of its clinical stages. However, only a few studies have specifically explored and characterized phagocytic activity during sepsis. Here, we describe the phagocytic processes that occur as part of the immune response preceding sepsis onset and identify the elements of phagocytosis that might constitute a predictive marker of sepsis outcomes. First, we detail the key features of phagocytosis, including the main receptors and signaling hallmarks associated with different phagocytic processes. We then discuss how the initial events of phagosome formation and cytoskeletal remodeling might be associated with known sepsis features, such as a cytokine-driven hyperinflammatory response and immunosuppression. Finally, we highlight the unresolved mechanisms of sepsis development and progression and the need for cross-disciplinary approaches to link the clinical complexity of the disease with basic cellular and molecular mechanisms.
PrintDisplayed: 28/8/2024 22:33